Literature DB >> 288725

Natural cytotoxic reactivity of human lymphocyte subpopulations.

M R Potter, M Moore.   

Abstract

The spontaneous cytotoxicity of human peripheral blood lymphocyte preparations from normal donors for K562 target cells was examined. Effector cells were separated into SRBC rosette forming cell (RFC) and non-rosette forming cell (non-RFC) fractions using optimal and suboptimal rosetting procedures. RFC and non-RFC fractions both had high cytotoxic activity irrespective of the rosetting procedure. Owing to the larger size of the RFC fraction, it contained a higher proportion of the total activity in the preparation. Nylon fibre column adherent and non-adherent fractions also both produced cytotoxicity. Nylon fibre non-adherent cells separated by SRBC separation gave a RFC fraction with low activity and a non-RFC fraction with high activity. Separation of nylon fibre adherent cells gave RFC and non-RFC fractions with high cytotoxic activity. Therefore cytotoxic cells did not form a discrete subpopulation and either occur in several lymphocyte subsets or show a variable capacity to form SRBC rosettes and adhere to nylon fibre.

Entities:  

Mesh:

Year:  1979        PMID: 288725      PMCID: PMC1457286     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  The effect of adherent and phagocytic cells on human lymphocyte PHA responsiveness.

Authors:  M R Potter; M Moore
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

2.  Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor.

Authors:  W H West; S M Payne; J L Weese; R B Herberman
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

Authors:  W H West; G B Cannon; H D Kay; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

4.  A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  H D Kay; G D Bonnard; W H West; R B Herberman
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

5.  Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures.

Authors:  T Bakács; P Gergely; S Cornain; E Klein
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

6.  Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients.

Authors:  S Gupta; R A Good
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

7.  Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte-mediated cytotoxicity.

Authors:  R L Vessella; B J Gormus; P H Lange; M E Kaplan
Journal:  Int J Cancer       Date:  1978-05-15       Impact factor: 7.396

8.  Identification of the effector cells in human blood displaying spontaneous cytotoxicity to chicken erythrocytes.

Authors:  E Saksela; P Häyry; L C Andersson
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

9.  Organ distribution of natural cytotoxicity in the rat.

Authors:  M R Potter; M Moore
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

10.  Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.

Authors:  G R Pape; M Troye; P Perlmann
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

View more
  14 in total

Review 1.  Lymphocyte-mediated lysis of tumor cells in vitro. Antigen-restricted clonal and unrestricted polyclonal effects.

Authors:  E Klein
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Effects of activated T cells on natural killing.

Authors:  R A Knight; P Fitzharris
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

3.  Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon.

Authors:  M R Potter; M Moore; A G Morris
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

4.  Proliferative response of lymphocyte subpopulations differing in avidity for sheep red blood cells after stimulation with normal allogeneic and tumour cells.

Authors:  L Matera; M R Potter; M Moore
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

5.  The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.

Authors:  M Richter; D Banerjee; S Sklar
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

6.  In vitro augmentation of human natural cytotoxic activity.

Authors:  M R Potter; M Moore
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

7.  Involvement of cell surface macromolecules sensitive to alkylating ketones in lysis by human peripheral blood NK cells.

Authors:  M M Dawson; U Shipton; M Moore
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

8.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

9.  Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes.

Authors:  M Moore; G M Taylor; W J White
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

10.  Isolation of human spontaneous killer lymphocytes by bacterial adherence.

Authors:  R Kleinman; K P De Boer; M Teodorescu
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.